Zobrazeno 1 - 10
of 71
pro vyhledávání: '"Peter H Levine"'
Autor:
Peter H. Levine
Publikováno v:
Scandinavian Journal of Haematology. 19:37-51
Autor:
Rent A. Vreker, Franco Panicucci, Hans‐Hermann Brackmann, Marc Verstraete, Tom H. Schmitz, Margareta Blombäck, Jean-Pierre Allain, Peter Jones, L. Jeanty, Robert Taub, Peter H. Levine, Aaron M. Josephson
Publikováno v:
Scandinavian Journal of Haematology. 19:75-77
Autor:
Van Cherington, Joyce Sobolewski, Hillard L. Rubin, Joel S. Greenberger, Anita Gaffney, Ti Wang, Claire A. Mcgrath, Peter H Levine, Shahin Emami, Gisela G. Chiang, Nava Sarver, David R. Hurwitz
Publikováno v:
Human Gene Therapy. 10:61-76
To evaluate the potential of the ex vivo bone marrow stromal cell (BMSC) system as a gene therapy for hemophilia A, we studied the in vitro expression of human factor VIII (hFVIII) in canine BMSCs following transfection with plasmid vectors and trans
Autor:
Michael J. Hansen, Michael Kirchgesser, Wilma Merrill, Gisela G. Chiang, Shahin Emami, Van Cherington, David R. Hurwitz, Joel S. Greenberger, Peter H Levine, Joseph M. Appel
Publikováno v:
In Vitro Cellular & Developmental Biology - Animal. 33:503-511
The ex vivo establishment, expansion, transduction, and reintroduction of autologous bone marrow stromal cells offers a potential efficacious system for somatic cell gene therapy. It is likely that any ex vivo system will require the use of large num
Autor:
Herbert A. Perkins, Peter H. Levine, C. H. Mielke, George W. Schneider, David L. Aronson, Milton M. Mozen
Publikováno v:
Journal of Clinical Apheresis. 8:131-135
Autor:
Richard S. Schwartz, Charles F. Abildgaard, Louis M. Aledort, Steven Arkin, Arthur L. Bloom, Hans H. Brackmann, Doreen B. Brettler, Hiromu Fukui, Margaret W. Hilgartner, Martin J. Inwood, Carol K. Kasper, Peter B.A. Kernoff, Peter H. Levine, Jeanne M. Lusher, Pier M. Mannucci, Inge Scharrer, Mary A. MacKenzie, Nazreen Pancham, Harng S. Kuo, Randy U. Allred
Publikováno v:
New England Journal of Medicine. 323:1800-1805
Background. Current treatment of hemophilia A, a hereditary disorder affecting approximately 1 in 10,000 males, relies on plasma-derived factor VIII concentrates. We tested the safety and efficacy of a recombinant factor VIII preparation for the trea
Publikováno v:
Stroke. 21:1435-1438
Leukocytes recruited to regions of focal cerebral ischemia may contribute to tissue injury by their ability to promote inflammation. A novel group of drugs, the 21-aminosteroids, have been observed to reduce neurologic damage and vasogenic cerebral e
Publikováno v:
Scandinavian Journal of Haematology. 33:459-460
At the request of the executive of the World Federation of Hemophilia, a uniform system for the classification of hemophilia centers has been devised. Three levels of centers are described: the hemophilia treatment unit, the comprehensive hemophilia
Autor:
Wilma Merrill, Anita Gaffney, Gisela G. Chiang, Joyce Sobolewski, Theofanis Galanopoulos, Christine B. Bizinkauskas, Joel S. Greenberger, Van Cherington, Michael J. Hansen, Peter H Levine, Claire A. Mcgrath, David R. Hurwitz
Publikováno v:
Human gene therapy. 9(10)
Canine bone marrow stromal cells (BMSCs), transduced ex vivo with retroviral vectors, expressed and secreted biologically active human and canine coagulation factor IX (hFIX and cFIX) in vitro, and on autologous reinfusion expressed hFIX into the cir
Autor:
Marc Fisher, D. A. Bergeron, Ronald A. Cohen, Margaret M. Arpano, James J. Hoogasian, Elizabeth M. Doyle, Peter H. Levine
Publikováno v:
Neurology. 41:297-297
Monocytes are recruited to active sites of multiple sclerosis (MS) demyelination and may promote local tissue injury by generating an inflammatory response, mediated in part by the production of toxic oxygen metabolites. Corticosteroids are frequentl